Catalyst Pharmaceuticals, Inc. (CPRX): Price and Financial Metrics
Catalyst Pharmaceuticals, Inc. (CPRX)
Today's Latest Price: $4.31 USD
0.00 (0.00%)
Updated May 29 4:00pm
Add CPRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CPRX Stock Summary
- The ratio of debt to operating expenses for Catalyst Pharmaceuticals Inc is higher than it is for about merely 5.73% of US stocks.
- Over the past twelve months, CPRX has reported earnings growth of -255.76%, putting it ahead of merely 6.56% of US stocks in our set.
- Revenue growth over the past 12 months for Catalyst Pharmaceuticals Inc comes in at 818.99%, a number that bests 99.1% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Catalyst Pharmaceuticals Inc are DIOD, VNDA, DGII, CAMT, and VIOT.
- CPRX's SEC filings can be seen here. And to visit Catalyst Pharmaceuticals Inc's official web site, go to www.catalystpharma.com.
CPRX Daily Price Range
CPRX 52-Week Price Range
CPRX Stock Price Chart More Charts
CPRX Price/Volume Stats
| Current price | $4.31 | 52-week high | $7.67 |
| Prev. close | $4.31 | 52-week low | $2.55 |
| Day low | $4.16 | Volume | 1,884,426 |
| Day high | $4.37 | Avg. volume | 2,048,757 |
| 50-day MA | $4.31 | Dividend yield | N/A |
| 200-day MA | $4.69 | Market Cap | 445.72M |
Catalyst Pharmaceuticals, Inc. (CPRX) Company Bio
Catalyst Pharmaceuticals focuses on the development and commercialization of prescription drugs targeting rare neurological diseases and disorders. The company was founded in 2002 and is based in Coral Gables, Florida.
Loading social stream, please wait...